We believe that technology development, on the one hand and the possibility for mass production, on the other hand, should provide as many people as possible with access to safe and efficient medications at a low cost. This is achieved either through the production of generic drugs or through the careful selection of prototype drugs bearing significant innovations. We are mostly interested in those two categories of medicinal products. We are proud of the trust that our partners show to us. We consider it to be one of our valuable assets. We are doing everything possible so that our partners are satisfied with this choice. BENNETT makes reality the most modern perceptions for the working environment, offering motivation and opportunities in a working framework governed by the principles of honesty, fairness and mutual respect. Quality is our strength: quality of our products, of our people and of the relationships we establish with the health professionals.
View Top Employees from BENNETT PHARMACEUTICALS S.AWebsite | http://www.bennett.gr |
Revenue | $14 million |
Employees | 97 (73 on RocketReach) |
Founded | 2005 |
Address | 20 Agias Kyriakis, Kifisiá 14561, GR |
Technologies | |
Industry | Pharmaceutical Manufacturing, Manufacturing General, Manufacturing |
Web Rank | 9 Million |
Keywords | Γαστροπροστασια, Bennet, Bennett, Isotonic Xylitol Solution, Bennett Korwpi |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies |
Looking for a particular BENNETT PHARMACEUTICALS S.A employee's phone or email?
The BENNETT PHARMACEUTICALS S.A annual revenue was $14 million in 2024.
73 people are employed at BENNETT PHARMACEUTICALS S.A.
The NAICS codes for BENNETT PHARMACEUTICALS S.A are [325, 32, 3254, 32541].
The SIC codes for BENNETT PHARMACEUTICALS S.A are [28, 283].